Ed Rosenthal, the world renowned cannabis advocate and horticulturist is preparing to embark on the latest development in his lengthy career as a cultivation icon – sitting on the proverbial throne of a company that plans to develop medical marijuana products.
THC Farmaceuticals announced that Rosenthal would be assuming the role as President of the company and will be working to develop a line of ganja goodies to be distributed across the country within the next year.
Under his role as company president, Rosenthal will not exactly be a slave to the corporate grind. He will assemble and manage a team of researchers on a mission to produce high quality “cannabinoid and non-cannabinoid based” edibles, oils and topicals.
“I appreciate the opportunity to lead this research program to develop new and better plant-based medicines,” Rosenthal said in a statement.
The news of Rosenthal’s latest venture comes on the heels of the appointment of former U.S. Senator Mike Gravel as the Chief Executive Officer of the firm. Senator Gravel, who is, perhaps, best known for his treacherous role in taking ‘The Pentagon Papers’ public during the Nixon Administration, was elected by THC Farmaceuticals to serve as the Chairman of the Board.
Interestingly, the ex-lawmaker is also the CEO of KUSH and serves on the board of directors at Cannabis Sativa, Inc – a company considered to be a leading player in the medical marijuana industry. Last year, Cannabis Sativa president and former New Mexico governor Gary Johnson said the company was the “Microsoft of marijuana,” after announcing his new-found leadership role with the Nevada-based company.
The recent appointment of Rosenthal as President of THC Farmaceuticals will allow the company to become a recognized leader in the nationwide cannabis trade.
What do you think of Ed Rosenthal joining THC Farmaceuticals? Tell us in the comments.
(Photo by Gracie Malley)